期刊文献+

美托洛尔治疗舒张期高血压对血糖的影响研究

The effect of Metoprolol on blood glucose in patients with diastolic hypertension
下载PDF
导出
摘要 目的:研究美托洛尔治疗舒张期高血压对血糖的影响。方法:我院2010~2012年收治舒张期高血压100例,其中50例作为对照组进行常规治疗;另50例为观察组,在常规基础上加用美托洛尔治疗;观察24个月,在治疗前后分别测定空腹及餐后2h血糖,并进行比较。结果:观察组治疗前及治疗24个月后舒张压分别为(108.5±8.9)mmHg、(78.2±7.8)mmHg,差异有统计学意义(t=18.10,P<0.05)。对照组治疗前及治疗24个月后舒张压分别为(112.8±10.8)mmHg、(67.4±12.1)mmHg,差异有统计学意义(t=19.80,P<0.05)。观察组和对照组比较无明显差异(P>0.05)。两组血糖比较,两组同组内治疗前后比较,差异显著(P<0.05);观察组与对照组治疗后比较,6个月血糖值无明显差异(P>0.05),12、24个月差异显著(P<0.05)。结论:使用美托洛尔治疗舒张期高血压降压效果较好,但可引起血糖升高。如长期使用美托洛尔治疗高血压,应注意血糖的监测与处理。 Objective :To study the effect of Metoprolol on blood glucose in patients with diastolic hypertension. Methods : 100 patients with di- astolic hypertension were divided into control group and observation group(50 cases in each group). The control group was given conventional treatment; on this basis, the observation group was given Metoprolol. Observation of 24 months, fasting blood glucose and 2h postprandial blood glucose were measured before and after treatment. Results: In the observation group, diastolic blood pressure before treatment was ( 108.5 ~ 8.9 ) mmHg, and diastolic blood pres- sure 24 months after treatment was (78.2 + 7.8 ) mmHg, there was statistical difference ( t = 18.10, P 〈 0.05 ). In the control group, diastolic blood pres- sure before treatment was ( 112.8 + 10.8 ) mmHg, and diastolic blood ibressure 24 months after treatment was ( 67.4 + 12.1 ) mmHg, there was statistical difference( t = 19.80 ,P 〈0.05 ). There was no significant difference between the two groups (P 〉 0.05 ). Conclusion: The effect of Metoprolol in the treatment of diastolic hypertension is better,but can cause hyperglycemia,attention should be paid to monitoring of blood glucose.
作者 邓文杰
出处 《中国民康医学》 2013年第24期3-3,22,共2页 Medical Journal of Chinese People’s Health
关键词 美托洛尔 舒张期高血压 血糖 Metoprelol Diastolie hypertension Blood glucose
  • 相关文献

二级参考文献31

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2刘志平.老年高血压患者高脉压现象与靶器官的损害[J].中国临床康复,2005,9(15):84-85. 被引量:5
  • 3李奕琏.老年高血压400例临床分析[J].中国医药,2006,1(3):149-150. 被引量:6
  • 4马虹,刘志军.β受体阻滞剂在治疗高血压病中的地位[J].中华心血管病杂志,2006,34(7):660-661. 被引量:22
  • 5诸骏仁,陶萍,刘国仗,王敬良,王宪衍,王育本,戴闺柱,范维琥,张丽蓉,李俭春.非洛地平缓释片每日一次治疗高血压病的疗效观察[J].中华心血管病杂志,1996,24(4):272-275. 被引量:71
  • 6Palatini P,Julis S. Review article: Association of tachycardia with morbidity and mortality: pathoohysiolgical considerations [J ]. J Hum Hypertens, 1997,11 (Suppl) : 19 - 27.
  • 7Kokkinos P, Chrysohoou C, Panagiotakos D, et al. Beta-blockade mitigates exercise blood pressure in hypertensive male patients [ J]. J Am Coll Cardiol, 2006,47 (4) :794-798.
  • 8Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction : results from the Controlled Abciximab and Device Investi- gation to Lower Late Angioplasty Complications ( CADILLAC ) trial [J].Circulation, 2004,110 ( 112 ) : 1598-1604.
  • 9Jawa A, Nachimuthu S, Pendergrass M, et al. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension [ J ]. J Diabetes Complications, 2008,22 (5) :303-308.
  • 10Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis [J]. Lance, 2005,366(9496) :1545-1553.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部